Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqing Yao

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Plos One|August 23, 2012
Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virusBaocheng Deng, Shujun Zhang, Yingzhi Geng, et al.
Plos One|January 28, 2014
Genetic polymorphism characteristics of Brucella canis isolated in ChinaDongdong Di, Buyun Cui, Heng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2022
Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1David M Burns, Chunhong He, Yun-Long Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 4, 2026
Reversible Oxygen Redox in Li-Rich Mn Based Cathodes Achieved by Regulating the Local Environments of Bulk and Surface Lattice OxygenZiqin Jiao, Tao Zeng, Wenhai Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3Xiangdong Liu, Qian Wang, Gengjie Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerJordan S Fridman, Eian Caulder, Michael Hansbury, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutationsDavid M Burns, Chunhong He, Yanlong Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Discovery of Pyrazolopyridine Derivatives as HPK1 InhibitorsQinda Ye, Kai Liu, Hai-Fen Ye, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Potent and selective aggrecanase inhibitors containing cyclic P1 substituentsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Plos One|August 23, 2012
Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virusBaocheng Deng, Shujun Zhang, Yingzhi Geng, et al.
Plos One|January 28, 2014
Genetic polymorphism characteristics of Brucella canis isolated in ChinaDongdong Di, Buyun Cui, Heng Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2022
Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1David M Burns, Chunhong He, Yun-Long Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 4, 2026
Reversible Oxygen Redox in Li-Rich Mn Based Cathodes Achieved by Regulating the Local Environments of Bulk and Surface Lattice OxygenZiqin Jiao, Tao Zeng, Wenhai Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3Xiangdong Liu, Qian Wang, Gengjie Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerJordan S Fridman, Eian Caulder, Michael Hansbury, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutationsDavid M Burns, Chunhong He, Yanlong Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionDavid M Burns, Yun-Long Li, Eric Shi, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Discovery of Pyrazolopyridine Derivatives as HPK1 InhibitorsQinda Ye, Kai Liu, Hai-Fen Ye, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Potent and selective aggrecanase inhibitors containing cyclic P1 substituentsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Pageof 11